Animal Models for Assessing Countermeasures to Bioterrorism Agents February 3-5, 2010

  Wednesday, February 3, 2010
9:30 – 11:00 am Dr. Steven Leary, Chair, AVMA Panel on Euthanasia
  Ethical considerations of euthanasia in biodefense research.
  Dr. Steve Niemi, Director, Center for Comparative Medicine,
  Massachusetts General Hospital
  Humane endpoints in infectious diseases and biodefense research.
11:00 am – 12:00 pm Dr. James Roth, Director, Center for Food Security and Public Health, Iowa State University
  Development of biological countermeasures for CBRN agents in animals: Lessons learned.
2:00 – 3:00 pm Dr. Nicholas Vietri, USAMRIID
  Fine-tuning animal models under the Animal Rule.
3:00 – 4:00 pm Dr. Drusilla Burns, FDA
  A conversation about the Animal Rule.
4:00 – 5:00 pm Ms. Hilde Boone, European Medicines Agency
  The European perspective on early approval mechanisms for new drugs.
  Thursday, February 4, 2010
9:00 – 10:00 am Dr. William Smith, Acting Deputy Commander, USAMRICD
  Development and licensure of pyridostigmine bromide under the Animal Rule.
  Dr. Renae L. Malek, Senior Scientist, Medical Identification and Treatment Systems
  Advanced developer Animal Rule perspective.
10:00 am - 12:00 pm Dr. Sally Bolmer, SVP, Human Genome Sciences
  Insights from development of an MCM for anthrax under the Animal Rule.
2:15 – 3:15 pm Dr. Andrew Rowan, EVP, The Humane Society of the United States
  Biodefense research and animal experimentation.

The National Academies | 500 Fifth St. N.W. | Washington, D.C. 20001
Copyright © National Academy of Sciences. All rights reserved.
Terms of Use and Privacy Statement